News

Prescriptions will be forwarded to another nearby location for customers. Auto service company acquires Bessemer distribution ...
Many people like to mock celebrities for using the various popular weight loss drugs. “Saturday Night Live” recently did a ...
Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...
CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...
CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...
The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...
CVS Health shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results ...
CVS Health ( NYSE: CVS) on Thursday announced plans to discontinue operations in the individual health insurance business, ...
CVS will exit Obamacare plans in 2026, affecting 1 million members across 17 states, and close stores amid pharmacy desert ...
CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...
Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...